ZTS — Zoetis Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1555280 ·
Last close
$76.84
Market Cap
$32.21B
52W High
$123.32
52W Low
$72.38
ADV30
8,270,781
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,262,000,000 | 1,621,000,000 | 822,000,000 | 601,000,000 | 15,154,000,000 | 1,940,000,000 | 11,921,000,000 |
| Dec 2025 | 2,387,000,000 | 1,675,000,000 | 826,000,000 | 603,000,000 | 15,467,000,000 | 2,310,000,000 | 12,136,000,000 |
| Sep 2025 | 2,400,000,000 | 1,717,000,000 | 936,000,000 | 721,000,000 | 15,159,000,000 | 2,080,000,000 | 9,761,000,000 |
| Jun 2025 | 2,460,000,000 | 1,811,000,000 | 989,000,000 | 718,000,000 | 14,479,000,000 | 1,435,000,000 | 9,502,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,790,000,000
Investing CF
$-632,000,000
Financing CF
$-2,033,000,000
CapEx
$-553,000,000
Dividends Paid
$-889,000,000
Buybacks
$-3,398,000,000
EPS Diluted TTM
$6.03
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$14,183,000,000
Inventory
$2,550,000,000
Receivables
$1,506,000,000
ST Investments
—
EBIT TTM
$3,538,000,000
Pretax Income TTM
$3,308,000,000
Interest Exp TTM
$230,000,000
Analysts
17
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,530,999,808
EBITDA
$4,073,999,872
Free Cash Flow
$1,780,875,008
Enterprise Value
$39,526,490,112
Total Cash
$1,940,999,936
Total Debt
$9,253,999,616
Shares Out
419,228,118
Trailing EPS
$6.10
Book Value
$7.84
ROE
67.7%
ROA
15.5%
Div Yield
2.76%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,467,000,000 | 3,597,000,000 | 2,673,000,000 | 15,467,000,000 | 12,136,000,000 | — | 2,904,000,000 |
| Dec 2024 | 9,256,000,000 | 3,392,000,000 | 2,486,000,000 | 14,237,000,000 | 9,467,000,000 | — | 2,953,000,000 |
| Dec 2023 | 8,544,000,000 | 3,069,000,000 | 2,344,000,000 | 14,286,000,000 | 9,295,000,000 | — | 2,353,000,000 |
| Dec 2022 | 8,080,000,000 | 2,928,000,000 | 2,114,000,000 | 14,925,000,000 | 10,522,000,000 | — | 1,912,000,000 |
TTM Snapshot
Revenues TTM
$8,531,000,000
NetIncome TTM
$2,359,000,000
OpCashFlow TTM
$0
Assets (Latest)
$14,237,000,000
Forward EPS
$7.42
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | $35.33B | $30.34 | — |
| BEIGF | BeOne Medicines Ltd. | $27.08B | $21.95 | — |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $38.48B | $288.18 | — |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $38.67B | $33.21 | — |
| ONC | BeOne Medicines Ltd. | $26.20B | $276.13 | — |
News headlines (Yahoo Finance, 1h cache)
Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?
2026-06-23 13:42 · Yahoo
2 Reasons to Like ZTS and 1 to Stay Skeptical
2026-06-22 15:23 · Yahoo
Zoetis (ZTS) Lost 22% in a Day; What Has Wall Street Worried?
2026-06-22 13:30 · Yahoo
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
2026-06-18 22:15 · Yahoo
What Makes Zoetis (ZTS) an Attractive Bet?
2026-06-17 14:16 · Yahoo
3 S&P 500 Stocks Worth Your Attention
2026-06-17 11:24 · Yahoo
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener
2026-06-15 18:38 · Yahoo
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
2026-06-12 22:15 · Yahoo
Zoetis (ZTS) Stock Draws Fresh Price Target Split After Difficult Q1 Update
2026-06-12 16:15 · Yahoo
PAHC Stock: What's Driving Phibro's Animal Health Growth
2026-06-12 12:27 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.